comprehensive -WSS

comprehensive

author：explore 2025-10-01 12:33:58 - browse：48

Peter Marks. -- health coverage from STAT — Peter Marks, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration. Susan Walsh-Pool/Getty Images

Peter Marks wants drug developers to ask more stupid questions.

It’s part of the top Food and Drug Administration official’s plan to reinvigorate gene therapy, a field that has struggled despite significant technological advances. Some companies are shelving programs or going out of business, even when they have promising data.

The problems are numerous: The diseases are often exceptionally rare, limiting the potential market. Manufacturing at commercial quality is complex and expensive. Proving a drug works can be difficult, because there may be too few patients to run a traditional randomized study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Kristina Burow of ARCH Venture Partners shares her next big bets STAT

leisure time

WSS

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Johnson & Johnson sued for allegedly overpaying for workers' drugs

RaDonda Vaught to speak at CommonSpirit event on patient safety

AstraZeneca loses challenge to Medicare drug price negotiation

RaDonda Vaught to speak at CommonSpirit event on patient safety

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

knowledge

comprehensive

knowledge

Peter Hotez and the public health issue of online harassment

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Hollywood unions extend contract negotiations for actors

Flu vaccine offering decent levels of protection this winter, new data show

Novavax promises a turnaround & Lilly roils the obesity market

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Trump demands the U.S. pay no more for drugs than other countries … again

Texas Medical Board asked to define abortion emergency exception

leisure time

RSV vaccines may be linked to small increased risk of developing GBS

Congress gives doctors Medicare pay bump

FDA does about

Why Novartis is going to walk from its acquisition of MorphoSys

ALS groups 'won't be played again' by the FDA, drug sponsors

Obesity now affects over 1 billion people worldwide, study finds

focus

hotspot

leisure time

hotspot